Pharos participated in the CPhI Worldwide exhibition, which this year took place in Frankfurt. CPhI has hosted more than 48,000 visiting pharma professionals over three days. […]

DECA Investments AIFM, the exclusive investment manager of Diorama Investments SICAR (“Diorama” or the “Fund”), announced the completion of the Fund’s ninth investment: the acquisition of […]

ELAIA ZEUS S.A., a company controlled by the Investment Fund Diorama Investments Sicar S.A. in which also participates the investment Fund Elikonos 2 SCA Sicar, announces […]

Pharos received the GMP certification for the production facility of Pharos Malta (Pharos MT). Pharos MT’s facility is located in Hal Far manufacturing site and has […]